The bioburden testing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 19.25% in the forecast period of 2021 to 2028.

Bioburden testing is a procedure of measuring viable microorganisms on medical devices, the raw material, or package. The procedure helps in determining parameters for its sterilization procedure to ensure safety and effectiveness of medical devices.